C-squared Pharma Ltd, based in Ireland, is a pharmaceutical company.
One of their notable products is BRIMONIDINE TARTRATE, with a corresponding US DMF Number 22510.
Remarkably, this DMF maintains an Active status since its submission on January 28, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on December 03, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II